{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:00:50Z","timestamp":1791874850015,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["6364-L"],"award-info":[{"award-number":["6364-L"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neurobiolaging.2021.09.016","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T21:58:52Z","timestamp":1632088732000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults"],"prefix":"10.1016","volume":"109","author":[{"given":"Antoine","family":"Hone-Blanchet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Bohsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-9510","authenticated-orcid":false,"given":"Lisa C.","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-6933","authenticated-orcid":false,"given":"Salman","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2497-1074","authenticated-orcid":false,"given":"David","family":"Loring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-4865","authenticated-orcid":false,"given":"Samantha E.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace C.","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-502X","authenticated-orcid":false,"given":"Allan","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8810-620X","authenticated-orcid":false,"given":"James","family":"Lah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-1755","authenticated-orcid":false,"given":"Deqiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Crosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0001","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1037\/1040-3590.7.2.220","article-title":"Effect of physical layout in performance of the trail making test","volume":"7","author":"Arnett","year":"1995","journal-title":"Psychol Assess..t"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0002","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/jmri.24665","article-title":"Decreased \u03b3-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease","volume":"41","author":"Bai","year":"2015","journal-title":"J Magn Reson Imaging."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0004","first-page":"1","article-title":"Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys A\u03b2 (1\u201342)","volume":"9","author":"Blennow","year":"2019","journal-title":"pTau and tTau CSF immunoassays. Scientific reports"},{"issue":"3-5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0005","first-page":"289","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"Brand","year":"1993","journal-title":"Dev Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0006","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.arr.2018.05.005","article-title":"From fetus to older age: a review of brain metabolic changes across the lifespan","volume":"46","author":"Cichocka","year":"2018","journal-title":"Ageing Res Rev."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neubiorev.2019.01.003","article-title":"Neurochemical changes in the aging brain: a systematic review","volume":"98","author":"Cleeland","year":"2019","journal-title":"Neurosci Biobehav Rev."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","article-title":"Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease","volume":"74","author":"Dean","year":"2017","journal-title":"JAMA Neurol."},{"issue":"22","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0009","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons","volume":"317","author":"Donohue","year":"2017","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jmri.24478","article-title":"Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid\u2013edited MR spectroscopy spectra","volume":"40","author":"Edden","year":"2014","journal-title":"J Magn Reson Imaging."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jagp.2016.12.021","article-title":"Amyloid-beta deposition is associated with increased medial temporal lobe activation during memory encoding in the cognitively normal elderly","volume":"25","author":"Edelman","year":"2017","journal-title":"Am J Geriatr Psychiatry."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-14159-1","article-title":"Functional brain architecture is associated with the rate of tau accumulation in alzheimer's disease","volume":"11","author":"Franzmeier","year":"2020","journal-title":"Nat Commun."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0013","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.3174\/ajnr.A3944","article-title":"Various MRS application tools for Alzheimer disease and mild cognitive impairment","volume":"35","author":"Gao","year":"2014","journal-title":"Am J Neuroradiol."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuroimage.2013.04.012","article-title":"Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels","volume":"78","author":"Gao","year":"2013","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0005-2760(89)90265-8","article-title":"Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin","volume":"1004","author":"Glanville","year":"1989","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism."},{"issue":"3-4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0016","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000501856","article-title":"Rationale and design of the emory healthy aging and emory healthy brain studies","volume":"53","author":"Goetz","year":"2019","journal-title":"Neuroepidemiology."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/87565648709540361","article-title":"Genuine memory deficits in dementia","volume":"3","author":"Grober","year":"1987","journal-title":"Dev Neuropsychol."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0018","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mrm.1910290613","article-title":"Automatic, localized in vivo adjustment of all first-and second-order shim coils","volume":"29","author":"Gruetter","year":"1993","journal-title":"Magn Reson Med."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0019","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1","article-title":"Field mapping without reference scan using asymmetric echo-planar techniques","volume":"43","author":"Gruetter","year":"2000","journal-title":"Magn Reson Med."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","article-title":"Alzheimer's disease: amino acid levels and brain metabolic status","volume":"34","author":"Gueli","year":"2013","journal-title":"Neurol Sci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0021","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neurobiolaging.2007.07.005","article-title":"A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging","volume":"30","author":"Haga","year":"2009","journal-title":"Neurobiol Aging."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0022","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jmri.24903","article-title":"Tissue correction for GABA-edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations","volume":"42","author":"Harris","year":"2015","journal-title":"J Magn Reson Imaging."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0023","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00001756-200201210-00041","article-title":"Proton MR spectroscopic study at 3 Tesla on glutamate\/glutamine in alzheimer's disease","volume":"13","author":"Hattori","year":"2002","journal-title":"Neuroreport."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0024","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau\u2014a toxic pas de deux in Alzheimer's disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat Rev Neurosci."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0026","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack Jr","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0027","first-page":"e1347","article-title":"Temporal dynamics of \u03b2-amyloid accumulation in aging and alzheimer disease","volume":"96","author":"Jagust","year":"2021","journal-title":"Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0028","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early A lzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0029","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.55.2.210","article-title":"Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study","volume":"55","author":"Kantarci","year":"2000","journal-title":"Neurol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0030","first-page":"843","article-title":"Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T","volume":"24","author":"Kantarci","year":"2003","journal-title":"Am J Neuroradiol."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0031","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.neurobiolaging.2006.06.018","article-title":"Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease","volume":"28","author":"Kantarci","year":"2007","journal-title":"v Neurobiol Aging."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0032","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e31829a3329","article-title":"MRI and MRS predictors of mild cognitive impairment in a population-based sample","volume":"81","author":"Kantarci","year":"2013","journal-title":"Neurol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0033","first-page":"752","article-title":"Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline\/creatine and myo-inositol\/creatine in a primate model","volume":"26","author":"Kim","year":"2005","journal-title":"Am J Neuroradiol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0034","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/mrm.21715","article-title":"Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T","volume":"60","author":"Kirov","year":"2008","journal-title":"Magn Reson Med."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuroimage.2017.05.049","article-title":"The association between tau PET and retrospective cortical thinning in clinically normal elderly","volume":"157","author":"LaPoint","year":"2017","journal-title":"Neuroimage."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer's disease","volume":"8","author":"Li","year":"2016","journal-title":"Front Aging Neurosci."},{"issue":"42","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0037","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1523\/JNEUROSCI.2883-19.2020","article-title":"Regional myo-inositol, creatine, and choline levels are higher at older age and scale negatively with visuospatial working memory: a cross-sectional proton MR spectroscopy study at 7 tesla on normal cognitive ageing","volume":"40","author":"Lind","year":"2020","journal-title":"J Neurosci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0038","doi-asserted-by":"crossref","first-page":"e3865","DOI":"10.1002\/nbm.3865","article-title":"Altered macromolecular pattern and content in the aging human brain","volume":"31","author":"Marja\u0144ska","year":"2018","journal-title":"NMR in Biomedicine."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0039","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuroscience.2017.04.035","article-title":"Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T","volume":"354","author":"Marja\u0144ska","year":"2017","journal-title":"Neurosci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3233\/JAD-170578","article-title":"Regional tau correlates of instrumental activities of daily living and apathy in mild cognitive impairment and Alzheimer's disease dementia","volume":"67","author":"Marshall","year":"2019","journal-title":"J Alzheimer's Dis."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol Neurodegener."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0042","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/nbm.1775","article-title":"Associations of age, gender and body mass with 1H MR-observed brain metabolites and tissue distributions","volume":"25","author":"Maudsley","year":"2012","journal-title":"NMR in Biomedicine"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0043","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ajog.2011.05.014","article-title":"Racial and regional differences in age at menopause in the United States: findings from the reasons for geographic and racial differences in stroke (REGARDS) study","volume":"205","author":"McKnight","year":"2011","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0044","doi-asserted-by":"crossref","first-page":"e31933","DOI":"10.1371\/journal.pone.0031933","article-title":"Frontal GABA levels change during working memory","volume":"7","author":"Michels","year":"2012","journal-title":"PloS one"},{"issue":"49","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0045","doi-asserted-by":"crossref","first-page":"16247","DOI":"10.1523\/JNEUROSCI.2027-14.2014","article-title":"Early Alzheimer's disease neuropathology detected by proton MR spectroscopy","volume":"34","author":"Murray","year":"2014","journal-title":"J Neurosci."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0046","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0047","doi-asserted-by":"crossref","first-page":"e4257","DOI":"10.1002\/nbm.4257","article-title":"Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts' consensus recommendations","volume":"34","author":"Near","year":"2021","journal-title":"NMR in Biomed."},{"issue":"13","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0048","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.0000000000004421","article-title":"1H-MRS metabolites and rate of \u03b2-amyloid accumulation on serial PET in clinically normal adults","volume":"89","author":"Nedelska","year":"2017","journal-title":"Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0049","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cercor\/bhx294","article-title":"Amyloid network topology characterizes the progression of Alzheimer's disease during the predementia stages","volume":"28","author":"Pereira","year":"2018","journal-title":"Cereb Cortex."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0050","doi-asserted-by":"crossref","first-page":"e62575","DOI":"10.7554\/eLife.62575","article-title":"The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies","volume":"10","author":"Porges","year":"2021","journal-title":"Elife."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0051","first-page":"38","article-title":"Frontal gamma-aminobutyric acid concentrations are associated with cognitive performance in older adults","volume":"2","author":"Porges","year":"2017","journal-title":"Biol Psychiatry Cogn."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","article-title":"A guide to the metabolic pathways and function of metabolites observed in human brain 1 H magnetic resonance spectra","volume":"39","author":"Rae","year":"2014","journal-title":"Neurochem Res."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0053","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/02841850903476564","article-title":"Metabolite concentrations in supraventricular white matter from teenage to early old age: a short echo time 1H magnetic resonance spectroscopy (MRS) study","volume":"51","author":"Raininko","year":"2010","journal-title":"Acta Radiol."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0054","article-title":"CSF tau and the CSF tau\/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","author":"Ritchie","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/gerona\/61.3.291","article-title":"Longitudinal changes during aging using proton magnetic resonance spectroscopy","volume":"61","author":"Ross","year":"2006","journal-title":"The J. Gerontol A Biol Sci Med Sci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0056","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0057","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.neurobiolaging.2021.09.016_bib0058","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nicl.2016.05.013","article-title":"Cortical amyloid burden and age moderate hippocampal activity in cognitively-normal adults","volume":"12","author":"Song","year":"2016","journal-title":"NeuroImage Clin."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0059","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","article-title":"Amyloid deposition is associated with impaired default network function in older persons without dementia","volume":"63","author":"Sperling","year":"2009","journal-title":"Neuron."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11682-013-9226-3","article-title":"MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer's disease","volume":"7","author":"Stoeckel","year":"2013","journal-title":"Brain Imaging Behav"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0061","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-002-0846-6","article-title":"Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis","volume":"249","author":"Tartaglia","year":"2002","journal-title":"J Neurol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0062","first-page":"e395","article-title":"Brain myoinositol as a potential marker of amyloid-related pathology: a longitudinal study","volume":"92","author":"Voevodskaya","year":"2019","journal-title":"Neurol.y"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.09.016_bib0063","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neurobiolaging.2012.09.014","article-title":"In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging","volume":"34","author":"Zahr","year":"2013","journal-title":"Neurobiol Aging."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:49:01Z","timestamp":1778676541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021002979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":63,"alternative-id":["S0197458021002979"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.09.016","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationships between frontal metabolites and Alzheimer's disease biomarkers in cognitively normal older adults","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}